Filter posts

Seattle Times Commentary: New Approaches Needed to Fight Ebola

In the Seattle Times this week, BIO Ventures for Global Health President Jennifer Dent offered …

BIO Presents at 2014 Biological Weapons Convention Meeting of Experts

Last week marked the annual Biological Weapons Convention (BWC) Meeting of Experts in Geneva. The …

Forbes: Faster FDA Approvals Have Not Caused More Drug Safety Problems

In 1992, Congress, industry, and the FDA worked together to create the Prescription Drug User Fee …

Jim Greenwood in WSJ: Curing Hepatitis C Is Cheaper Than Open-Ended Care

On Friday, a letter from BIO President and CEO Jim Greenwood was published in the …

Fighting Ebola with Tobacco

Years in the making, the Ebola virus has recently erupted into a full blown health …

Delivering on Biotech’s Promise to Treat Anthrax, Smallpox, Ebola

Thanks to federal biodefense programs that partner with industry to develop and stockpile medical countermeasures, …

Decoding Genes to find Breast Cancer

Today, August 7, 2014, researchers at the University Medical Center Utrecht announced that they have identified a …

New study shows hepatitis C burden may ease in future

Anew study published in the Annals of Internal Medicine projects that the prevalence of hepatitis …

NYT Columnist: Insurance Industry “Looking at the Costs of Sovaldi in the Wrong Way”

Margot Sanger-Katz’s article on a new drug that treats hepatitis C notes that despite the …

Treating Hepatitis C: Too Costly Not to Act

Today, The Hill published an op-ed – Treating hepatitis C: Too costly not to act …